UPR-Activated IRE1 Signaling Pathway Promotes Malignant Growth of Breast Cancer

Xinyu Fan; Zhiqi  Zhu; Ziyi Zhao

doi:10.62051/x8stye67

Authors

Xinyu Fan
Zhiqi Zhu
Ziyi Zhao

DOI:

https://doi.org/10.62051/x8stye67

Keywords:

Endoplasmic reticulum stress; UPR; IRE1; RIDD; breast cancer.

Abstract

Initially, it was believed that the unfolded protein response (UPR) was a network signal that synchronized apoptotic and adaptive responses to the buildup of unfolded proteins in the endoplasmic reticulum (ER). The endoplasmic reticulum stress sensor IRE1 is a major player in the UPR, and overactivation of IRE1 can promote a variety of pathological phenomena, such as diabetes, neurodegenerative diseases, and cancer. Under endoplasmic reticulum stress, IRE1 is activated through autophosphorylation and oligomerization, leading to conformational changes in the RNase domain, thereby promoting two signaling pathways: 1) unconventional splicing of XBP1 and 2) regulated IRE1 dependence Decay (RIDD). Research has revealed that aggressive B-type breast cancer cells typically have an overexpressed and amplified IRE1 gene. Through the RIDD mechanism, IRE1 processes and regulates the breakdown of a fraction of tumor-suppressing micro-RNA, which in breast cancer cells results in the Ras oncogene GTPase. RAB3B is elevated. This article reveals the mechanism of action of the IRE1 signaling pathway and the RIE1-RIDD-miRNA pathway in promoting the malignant development of luminal breast cancer.

Downloads

Download data is not yet available.

References

McLaughlin, T., et al., Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications. Mol Neurodegener, 2022. 17 (1): p. 25.

Henkel, A. and R.M. Green, The unfolded protein response in fatty liver disease. Semin Liver Dis, 2013. 33 (4): p. 321 - 9.

Zhang, S.X., et al., Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. Exp Eye Res, 2014. 125: p. 30 - 40.

Han, C.C. and F.S. Wan, New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer Metastasis. J Breast Cancer, 2018. 21 (4): p. 354 - 362.SHI Biao, LI Yu Xia, YU Xhua, YAN Wang. Short-term load forecasting based on modified particle swarm optimizer and fuzzy neural network model. Systems Engineering-Theory and Practice, 2010, 30 (1): 158 - 160.

Schröder, M., The unfolded protein response. Mol Biotechnol, 2006. 34 (2): p. 279 - 90.

Zhou, J., et al., The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response. Proc Natl Acad Sci U S A, 2006. 103 (39): p. 14343 - 8.

Li, H., et al., Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering. Proc Natl Acad Sci U S A, 2010. 107 (37): p. 16113 - 8.

Martín-Pérez, R., et al., Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway. Cancer Res, 2014. 74 (6): p. 1766 - 77.

Wang, J.M., et al., IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs. Sci Signal, 2018. 11 (530).

Jääskeläinen, A., et al., High Parity Predicts Poor Outcomes in Patients with Luminal B-like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study. Front Oncol, 2020. 10: p. 1470.

Ye, F., et al., miR-200b as a prognostic factor in breast cancer targets multiple members of the RAB family. J Transl Med, 2014. 12: p. 17.

Chalmers, F., et al., The multiple roles of the unfolded protein response regulator IRE1α in cancer. Mol Carcinog, 2019. 58 (9): p. 1623 - 1630.

Zhang K, Liu H, Song Z, et al., The UPR Transducer IRE1 Promotes Breast Cancer Malignancy by Degrading Tumor Suppressor microRNAs. iScience., 2020. 23 (9).

Wang, M., et al., The unfolded protein response as a target for anticancer therapeutics. Crit Rev Oncol Hematol, 2018. 127: p. 66 - 79.

Keenan, M. M., C.K. Ding, and J.T. Chi, an unexpected alliance between stress responses to drive oncogenesis. Breast Cancer Res, 2014. 16 (6): p. 471.